Single chain antibody (scFv)

Industry

CPC
C07K2317/622

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K2317/00Immunoglobulins specific feautures

Current Industry

C07K2317/622Single chain antibody (scFv)

Industries

Patents Grantslast 30 patents

Information Patent Grant
Therapeutic antibody fragments, methods of making, and methods of use
- Patent number 12,145,991
- Issue date Nov 19, 2024
- UNM Rainforest Innovations
- Karin Westlund High
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PTK7 immune cell cancer therapy
- Patent number 12,146,157
- Issue date Nov 19, 2024
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for car T cell therapy
- Patent number 12,144,850
- Issue date Nov 19, 2024
- Purdue Research Foundation
- Philip Stewart Low
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for imaging
- Patent number 12,144,875
- Issue date Nov 19, 2024
- TAYU HUAXIA BIOTECH MEDICAL GROUP CO., LTD.
- Lieping Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-human transferrin receptor antibody capable of penetrating blo...
- Patent number 12,145,995
- Issue date Nov 19, 2024
- JCR Pharmaceuticals Co., Ltd.
- Hiroyuki Sonoda
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of allergic diseases with chimeric protein
- Patent number 12,146,001
- Issue date Nov 19, 2024
- North Carolina State University
- Bruce Hammerberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,145,007
- Issue date Nov 19, 2024
- DEKA BIOSCIENCES INC.
- John Mumm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cell modification and use thereof
- Patent number 12,145,990
- Issue date Nov 19, 2024
- ADAPTIMMUNE LIMITED
- Garth Hamilton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating dry eye disease using TNF alpha antagonists
- Patent number 12,146,187
- Issue date Nov 19, 2024
- Novartis AG
- Yunsheng He
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bispecific and tetravalent CD137 and FAP molecules for the treatmen...
- Patent number 12,146,000
- Issue date Nov 19, 2024
- Boehringer Ingelheim International GmbH
- Eric Borges
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for decreasing soluble immune receptor CD28
- Patent number 12,139,534
- Issue date Nov 12, 2024
- BIOND BIOLOGICS LTD.
- Motti Hakim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EphA3 directed CAR-T cells for treatment of tumors
- Patent number 12,139,544
- Issue date Nov 12, 2024
- Mayo Foundation for Medical Education and Research
- Cameron Durrant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified chimeric receptors and related compositions and methods
- Patent number 12,139,526
- Issue date Nov 12, 2024
- Juno Therapeutics, Inc.
- Lucas James Thompson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 12,139,816
- Issue date Nov 12, 2024
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Monoclonal antibody against canine fibroblast activation protein th...
- Patent number 12,139,550
- Issue date Nov 12, 2024
- The Trustees of the University of Pennsylvania
- Ellen Puré
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
T-cells comprising two different chimeric antigen receptors and use...
- Patent number 12,139,522
- Issue date Nov 12, 2024
- THE MEDICAL RESEARCH INFRASTRUCTURE AND HEAL SERVICED FUND OF THE TEL AVIV ME...
- Zelig Eshhar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...
- Patent number 12,139,538
- Issue date Nov 12, 2024
- Memorial Sloan Kettering Cancer Center
- Renier J. Brentjens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Material and methods for treating or preventing HER-3 associated di...
- Patent number 12,139,549
- Issue date Nov 12, 2024
- Daiichi Sankyo Europe GmbH
- Thore Hettmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for improving affinity of antibody for antigen and use thereof
- Patent number 12,139,552
- Issue date Nov 12, 2024
- Sysmex Corporation
- Shingo Maeta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immune cell compositions and methods of use
- Patent number 12,139,524
- Issue date Nov 12, 2024
- Memorial Sloan Kettering Cancer Center
- Prasad S. Adusumilli
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Universal anti-CD22 chimeric antigen receptor engineered immune cells
- Patent number 12,133,867
- Issue date Nov 5, 2024
- Cellectis SA
- Julianne Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Interleukin 18 (IL-18) variants and fusion proteins comprising same
- Patent number 12,134,635
- Issue date Nov 5, 2024
- SONNET BIOTHERAPEUTICS, INC.
- John K. Cini
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Binding molecules
- Patent number 12,134,647
- Issue date Nov 5, 2024
- Immunocore Limited
- Jakub Jaworski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constrained conditionally activated binding proteins
- Patent number 12,128,102
- Issue date Oct 29, 2024
- Takeda Pharmaceutical Company Limited
- Patrick Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using chimeric antigen receptor and protein kin...
- Patent number 12,128,069
- Issue date Oct 29, 2024
- The Trustees of the University of Pennsylvania
- Steven M. Albelda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting CLPTM1L for treatment and prevention of cancer
- Patent number 12,129,305
- Issue date Oct 29, 2024
- The Medical College of Wisconsin, Inc.
- Michael A. James
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 12,129,309
- Issue date Oct 29, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single cell bar-coding for antibody discovery
- Patent number 12,129,462
- Issue date Oct 29, 2024
- AbVitro LLC
- Francois Vigneault
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-GPC3 antibody
- Patent number 12,129,291
- Issue date Oct 29, 2024
- Yamaguchi University
- Koji Tamada
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions including CD3 antigen binding fragments and uses thereof
- Patent number 12,129,298
- Issue date Oct 29, 2024
- Daiichi Sankyo Company, Limited
- Thomas Spreter Von Kreudenstein
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION
- Publication number 20240384007
- Publication date Nov 21, 2024
- Novartis AG
- James E. Bradner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC BINDING PROTEINS THAT BIND CD137 AND A TUMOR ASSOCIATED...
- Publication number 20240383978
- Publication date Nov 21, 2024
- NOVAROCK BIOTHERAPEUTICS, LTD.
- Yi Pei
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD3/CD25 Antibodies For Neuro-Immune Diseases
- Publication number 20240383980
- Publication date Nov 21, 2024
- Vitruviae LLC
- Mahiuddin Ahmed
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use Thereof
- Publication number 20240383983
- Publication date Nov 21, 2024
- ABL BIO, INC.
- Kyungjin PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES
- Publication number 20240383986
- Publication date Nov 21, 2024
- Oxford University Innovation Limited
- Graham OGG
- G01 - MEASURING TESTING
Information Patent Application
ASYMMETRIC ANTIBODY WITH IMPROVED CYTOTOXICITY AGAINST CANCER CELLS
- Publication number 20240383998
- Publication date Nov 21, 2024
- Korea University Research and Business Foundation
- Sang Taek JUNG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR AND CAR-T CELLS THAT BIND BCMA
- Publication number 20240382522
- Publication date Nov 21, 2024
- MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT
- Armin Rehm
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODY AND ANTIGEN BINDING FRAGMENTS THEREOF
- Publication number 20240385186
- Publication date Nov 21, 2024
- Philip Morris Products S.A.
- Laura FRANCIUS
- G01 - MEASURING TESTING
Information Patent Application
MATERIALS AND METHODS FOR ENHANCED STEM-CELL LIKE MEMORY T CELL ENG...
- Publication number 20240384231
- Publication date Nov 21, 2024
- JANSSEN BIOTECH, INC.
- Madhusudhanan SUKUMAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HINGE-MODIFIED BISPECIFIC ANTIBODIES
- Publication number 20240383990
- Publication date Nov 21, 2024
- DIAGONAL THERAPEUTICS INC.
- Alexey Alexandrovich Lugovskoy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 AND CD22 TARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIF...
- Publication number 20240384006
- Publication date Nov 21, 2024
- AMGEN RESEARCH (MUNICH) GMBH
- Marc Panzer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OFF-THE-SHELF IPSC-DERIVED CAR-NK CELL AS MONOTHERAPY AND IN COMBIN...
- Publication number 20240382523
- Publication date Nov 21, 2024
- FATE THERAPEUTICS, INC.
- Bahram VALAMEHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD4+ AND/OR CD8+ CELL POPULATIONS COMPRISING ICARS FOR USE IN TREAT...
- Publication number 20240382525
- Publication date Nov 21, 2024
- Gavish-Galilee Bio Applications Ltd.
- Michael WEIST
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELLULAR THERAPY TO SUPPRESS IMMUNE RESPONSE
- Publication number 20240382587
- Publication date Nov 21, 2024
- THE TRUSTEES OF INDIANA UNIVERSITY
- Moanaro BISWAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Monoclonal Antibody Against Canine Fibroblast Activation Protein th...
- Publication number 20240384004
- Publication date Nov 21, 2024
- The Trustees of the University of Pennsylvania
- Ellen Puré
- G01 - MEASURING TESTING
Information Patent Application
BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
- Publication number 20240383992
- Publication date Nov 21, 2024
- Oricell Therapeutics Co., Ltd.
- Siye CHEN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO...
- Publication number 20240376197
- Publication date Nov 14, 2024
- The Trustees of the University of Pennsylvania
- Marco Ruella
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS
- Publication number 20240376201
- Publication date Nov 14, 2024
- H. Lee Moffitt Cancer Center & Research Institute, Inc.
- Marco L. Davila
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNIVERSAL CAR-T CELL TARGETING IL13RALPHA2, PREPARATION METHOD THER...
- Publication number 20240376216
- Publication date Nov 14, 2024
- NINGBO T-MAXIMUM BIOPHARMACEUTICALS CO., LTD.
- Xiaoyun SHANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TFR ANTIGEN BINDING PROTEINS AND USES THEREOF
- Publication number 20240376222
- Publication date Nov 14, 2024
- The Board of Regents of the University of Texas System
- Zhiqiang AN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD21 ANTIBODIES AND USES THEREOF
- Publication number 20240376225
- Publication date Nov 14, 2024
- The Children's Medical Center Corporation
- Hulian GAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS
- Publication number 20240376226
- Publication date Nov 14, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF
- Publication number 20240376203
- Publication date Nov 14, 2024
- Trustees of Tufts College
- Peter A. Bullock
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEASE-ACTIVATED POLYPEPTIDES
- Publication number 20240376171
- Publication date Nov 14, 2024
- HOFFMANN-LA ROCHE INC.
- Samuele CALABRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-VIRUS MOIETY IMMOBILISED IN A MATRIX
- Publication number 20240376182
- Publication date Nov 14, 2024
- SAMATVA RESEARCH CORPORATION
- Sanjoy Kumar Gupta
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
GENERATION OF CAR MODIFIERS FOR TUMOR TREATMENT
- Publication number 20240374641
- Publication date Nov 14, 2024
- The Trustees of the University of Pennsylvania
- Donald M. O'Rourke
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HERV-K ANTIBODY THERAPEUTICS
- Publication number 20240374644
- Publication date Nov 14, 2024
- SunnyBay BioTech, Inc.
- Feng WANG-JOHANNING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INTERLEUKIN 2 CHIMERIC CONSTRUCTS WITH TARGETING SPECIFICY TO INFLA...
- Publication number 20240376172
- Publication date Nov 14, 2024
- ILTOO PHARMA
- David KLATZMANN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF
- Publication number 20240374718
- Publication date Nov 14, 2024
- Scholar Rock, Inc.
- Michelle Straub
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND...
- Publication number 20240374721
- Publication date Nov 14, 2024
- Takeda Pharmaceutical Company Limited
- Chihiro Take
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Single chain antibody (scFv)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Therapeutic antibody fragments, methods of making, and methods of use

Anti-PTK7 immune cell cancer therapy

Methods and compositions for car T cell therapy

Compositions and methods for imaging

Anti-human transferrin receptor antibody capable of penetrating blo...

Treatment of allergic diseases with chimeric protein

Dual cytokine fusion proteins comprising IL-10

T cell modification and use thereof

Methods of treating dry eye disease using TNF alpha antagonists

Bispecific and tetravalent CD137 and FAP molecules for the treatmen...

Methods and compositions for decreasing soluble immune receptor CD28

EphA3 directed CAR-T cells for treatment of tumors

Modified chimeric receptors and related compositions and methods

Protease-resistant systems for polypeptide display and methods of m...

Monoclonal antibody against canine fibroblast activation protein th...

T-cells comprising two different chimeric antigen receptors and use...

Chimeric antigen receptors targeting Fc receptor-like 5 and uses th...

Material and methods for treating or preventing HER-3 associated di...

Method for improving affinity of antibody for antigen and use thereof

Immune cell compositions and methods of use

Universal anti-CD22 chimeric antigen receptor engineered immune cells

Interleukin 18 (IL-18) variants and fusion proteins comprising same

Binding molecules

Constrained conditionally activated binding proteins

Treatment of cancer using chimeric antigen receptor and protein kin...

Targeting CLPTM1L for treatment and prevention of cancer

Heterodimeric antibodies that bind CD3 and CD38

Single cell bar-coding for antibody discovery

Anti-GPC3 antibody

Compositions including CD3 antigen binding fragments and uses thereof

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION

BISPECIFIC BINDING PROTEINS THAT BIND CD137 AND A TUMOR ASSOCIATED...

CD3/CD25 Antibodies For Neuro-Immune Diseases

Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use Thereof

ANTIBODIES

ASYMMETRIC ANTIBODY WITH IMPROVED CYTOTOXICITY AGAINST CANCER CELLS

CHIMERIC ANTIGEN RECEPTOR AND CAR-T CELLS THAT BIND BCMA

ANTIBODY AND ANTIGEN BINDING FRAGMENTS THEREOF

MATERIALS AND METHODS FOR ENHANCED STEM-CELL LIKE MEMORY T CELL ENG...

HINGE-MODIFIED BISPECIFIC ANTIBODIES

CD20 AND CD22 TARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIF...

OFF-THE-SHELF IPSC-DERIVED CAR-NK CELL AS MONOTHERAPY AND IN COMBIN...

CD4+ AND/OR CD8+ CELL POPULATIONS COMPRISING ICARS FOR USE IN TREAT...

CELLULAR THERAPY TO SUPPRESS IMMUNE RESPONSE

Monoclonal Antibody Against Canine Fibroblast Activation Protein th...

BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO...

COMPOSITIONS AND METHODS FOR TARGETING CD33-EXPRESSING CANCERS

UNIVERSAL CAR-T CELL TARGETING IL13RALPHA2, PREPARATION METHOD THER...

TFR ANTIGEN BINDING PROTEINS AND USES THEREOF

CD21 ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS

ANTI-PD-1 IMMUNOGLOBULIN POLYPEPTIDES AND USES THEREOF

PROTEASE-ACTIVATED POLYPEPTIDES

ANTI-VIRUS MOIETY IMMOBILISED IN A MATRIX

GENERATION OF CAR MODIFIERS FOR TUMOR TREATMENT

HERV-K ANTIBODY THERAPEUTICS

INTERLEUKIN 2 CHIMERIC CONSTRUCTS WITH TARGETING SPECIFICY TO INFLA...

ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF

CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND...